Plethico Pharmaceuticals Ltd.
NSE: PLETHICO | BSE: 532739
₹7.94
₹-0.41
(-4.91%)
As on 13-Jun-2016IST
Market cap
₹27 Cr
Revenue (TTM)
₹765 Cr
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-278 Cr
-
ROE
7.4 %
-
ROCE
9.8 %
-
Industry P/E
39.76
-
EV/EBITDA
12.2
-
Debt to Equity
0.3
-
Book Value
₹--
-
EPS
₹-13.2
-
Face value
10
-
Shares outstanding
34,066,667
10 Years Aggregate
CFO
₹551.70 Cr
EBITDA
₹1,676.79 Cr
Net Profit
₹1,330.21 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Plethico Pharmaceuticals
| -39.8 | -5.6 | -21.9 | -70.6 | -67.1 | -53.2 | -29.9 |
|
BSE Sensex*
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
BSE Healthcare#
| 18.8 | 2.8 | 8.7 | 17.1 | 23.1 | 14.8 | 12.4 |
|
Company
|
2015
|
2014
|
|---|---|---|
|
Plethico Pharmaceuticals
| -68.6 | -19.6 |
|
BSE Sensex
| -5.0 | 29.9 |
|
BSE Healthcare
| 15.1 | 47.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Plethico Pharmaceuticals
|
7.9 | 27.1 | 765.1 | -277.7 | 7.2 | -3.1 | -- | 0.0 |
| 3,281.6 | 26,914.3 | 1,461.8 | 387.4 | 34.5 | 25.2 | 69.7 | 15.6 | |
| 813.5 | 15,965.8 | 7,784.0 | 688.5 | 10.6 | 14 | 23 | 2.7 | |
| 449.9 | 17,224.5 | 2,141.5 | 58.5 | 5.8 | 3.3 | 162.1 | 4.5 | |
| 836.7 | 20,787.7 | 5,632.3 | 662.4 | 17.2 | 14.3 | 31.4 | 4.2 | |
| 1,532.2 | 17,601.1 | 1,543.3 | -48.6 | 3.6 | -0.6 | -- | 3.0 | |
| 218.7 | 29,076.6 | 9,205.3 | -371.8 | 1.7 | -3.8 | -- | 3.6 | |
| 1,804.4 | 30,002.7 | 1,935.8 | 288.2 | 20.6 | 29.8 | 104.1 | 22.4 | |
| 403.4 | 16,296.1 | 3,600.2 | 221.0 | 9.7 | 5.6 | 73.7 | 3.4 | |
| 1,977.1 | 32,309.1 | 3,564.0 | 414.0 | 15.3 | 8.4 | 79 | 6.4 |
Shareholding Pattern
View DetailsNews & Analysis
All News
Stocks are not always the best option
5 min read•By Research Desk
2 min read•By Research Desk
About Plethico Pharmaceuticals
Manufacture of allopathic pharmaceutical preparations
-
Incorporated
1991
-
Chairman
Shashikant Patel
-
Managing Director
Shashikant Patel
-
Headquarters
Indore Dist, Madhya Pradesh
-
Website
Looking for more details about Plethico Pharmaceuticals Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Plethico Pharmaceuticals
What is the current share price of Plethico Pharmaceuticals Ltd Today?
The share price of Plethico Pharmaceuticals Ltd is ₹7.94 (BSE) and ₹21.55 (NSE) as of 13-Jun-2016 IST. Plethico Pharmaceuticals Ltd has given a return of -67.06% in the last 3 years.
What is the current PB & PE ratio of Plethico Pharmaceuticals Ltd?
Since, TTM earnings of Plethico Pharmaceuticals Ltd is negative, P/E ratio is not available.
The P/B ratio of Plethico Pharmaceuticals Ltd is 0.02 times as on 13-Jun-2016, a 100 discount to its peers’ median range of 4.21 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2012 |
10.26 |
0.76 |
2011 |
11.70 |
0.90 |
2010 |
5.44 |
1.18 |
2009 |
6.42 |
1.46 |
2008 |
2.16 |
0.57 |
What is the 52 Week High and Low of Plethico Pharmaceuticals Ltd?
The 52-week high and low of Plethico Pharmaceuticals Ltd are Rs -- and Rs -- as of 28-Aug-2026.
What is the market cap of Plethico Pharmaceuticals Ltd?
Plethico Pharmaceuticals Ltd has a market capitalisation of ₹ 27 Cr as on 13-Jun-2016. As per SEBI classification, it is a company.
Should I invest in Plethico Pharmaceuticals Ltd?
Before investing in Plethico Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.